The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

This CTD dossier owner and manufacturer specializes in the manufacturing, import, and export of a diverse range of healthcare products. Their portfolio includes over 300 registered pharmaceutical products spanning various therapeutic areas, primarily delivered through tablets, capsules, dry suspensions, injectables, and sachets. The company operates a state-of-the-art manufacturing facility equipped with modern technology to ensure high-quality production according to international standards. They are committed to research and development, aiming to provide innovative healthcare solutions globally. Their focus extends beyond manufacturing, encompassing market research and the promotion of pharmaceutical products across regions like the EU and North America.